The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 14,801 | 1,437,028 | SH | SOLE | 1,437,028 | 0 | 0 | ||
| ALLENA PHARMACEUTICALS INC | COM | 018119107 | 4,929 | 3,330,373 | SH | SOLE | 3,330,373 | 0 | 0 | ||
| ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 22,603 | 2,571,450 | SH | SOLE | 2,571,450 | 0 | 0 | ||
| ANAPTYSBIO INC | COM | 032724106 | 34,168 | 2,316,447 | SH | SOLE | 2,316,447 | 0 | 0 | ||
| APTINYX INC | COM | 03836N103 | 10,782 | 3,190,079 | SH | SOLE | 3,190,079 | 0 | 0 | ||
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 308,904 | 10,542,790 | SH | SOLE | 10,542,790 | 0 | 0 | ||
| BELLICUM PHARMACEUTICALS INC | COM NEW | 079481404 | 691 | 105,144 | SH | SOLE | 105,144 | 0 | 0 | ||
| BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 2,959 | 1,296,743 | SH | SOLE | 1,296,743 | 0 | 0 | ||
| CARDIFF ONCOLOGY INC | COM | 14147L108 | 3,689 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 3,740 | 1,312,258 | SH | SOLE | 1,312,258 | 0 | 0 | ||
| COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 19,647 | 943,666 | SH | SOLE | 943,666 | 0 | 0 | ||
| ENTASIS THERAPEUTICS HLDGS I | COM | 293614103 | 408 | 199,953 | SH | SOLE | 199,953 | 0 | 0 | ||
| FREELINE THERAPEUTICS HLDGS | SPONSORED ADS | 35655L107 | 8,586 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
| GRITSTONE ONCOLOGY INC | COM | 39868T105 | 5,464 | 2,061,758 | SH | SOLE | 2,061,758 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 43,224 | 1,312,999 | SH | SOLE | 1,312,999 | 0 | 0 | ||
| ITERUM THERAPEUTICS PLC | SHS | G6333L101 | 1,615 | 1,538,316 | SH | SOLE | 1,538,316 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 13,336 | 2,364,500 | SH | SOLE | 2,364,500 | 0 | 0 | ||
| KRYSTAL BIOTECH INC | COM | 501147102 | 38,530 | 895,000 | SH | SOLE | 895,000 | 0 | 0 | ||
| MINERVA NEUROSCIENCES INC | COM | 603380106 | 1,749 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
| MIRUM PHARMACEUTICALS INC | COM | 604749101 | 68,734 | 3,566,912 | SH | SOLE | 3,566,912 | 0 | 0 | ||
| NABRIVA THERAPEUTICS PLC | SHS | G63637105 | 2,269 | 4,256,526 | SH | SOLE | 4,256,526 | 0 | 0 | ||
| PASSAGE BIO INC | COM | 702712100 | 65,671 | 5,009,219 | SH | SOLE | 5,009,219 | 0 | 0 | ||
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 213,691 | 5,827,415 | SH | SOLE | 5,827,415 | 0 | 0 | ||
| REGENXBIO INC | COM | 75901B107 | 4,794 | 174,200 | SH | SOLE | 174,200 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 12,070 | 528,000 | SH | SOLE | 528,000 | 0 | 0 | ||
| SIERRA ONCOLOGY INC | COM NEW | 82640U404 | 2,164 | 202,803 | SH | SOLE | 202,803 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 19,484 | 1,320,045 | SH | SOLE | 1,320,045 | 0 | 0 | ||
| TRANSLATE BIO INC | COM | 89374L104 | 29,708 | 2,182,789 | SH | SOLE | 2,182,789 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 39,555 | 2,788,443 | SH | SOLE | 2,788,443 | 0 | 0 | ||
| VAXCYTE INC | COM | 92243G108 | 114,046 | 2,309,554 | SH | SOLE | 2,309,554 | 0 | 0 | ||
| VTV THERAPEUTICS INC | CL A | 918385105 | 1,880 | 1,062,000 | SH | SOLE | 1,062,000 | 0 | 0 | ||